ANXA11 was found upregulated in gastric tumors compared to normal tissue, and increased ANXA11 levels were significantly associated with tumor size and infiltration, lymph node metastasis, TNM stage and vascular invasion, emerging as a bad prognosis factor and a potential therapeutic target for this cancer type. The gene discussed is ANXA11; the disease is neoplasm.